Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Tamio Mizukami is active.

Publication


Featured researches published by Tamio Mizukami.


Journal of Biological Chemistry | 1998

Radicicol Leads to Selective Depletion of Raf Kinase and Disrupts K-Ras-activated Aberrant Signaling Pathway

Shiro Soga; Takako Kozawa; Hiroaki Narumi; Shiro Kyowa Hakko Kogyo Co. Ltd. Akinaga; Kenji Irie; Kunihiro Matsumoto; Sreenath V. Sharma; Hirofumi Nakano; Tamio Mizukami; Mitsunobu Hara

Activation of Ras leads to the constitutive activation of a downstream phosphorylation cascade comprised of Raf-1, mitogen-activated protein kinase (MAPK) kinase, and MAPK. We have developed a yeast-based assay in which the Saccharomyces cerevisiae mating pheromone-induced MAPK pathway relied on co-expression of K-Ras and Raf-1. Radicicol, an antifungal antibiotic, was found to inhibit the K-ras signaling pathway reconstituted in yeast. In K-ras-transformed, rat epithelial, and K-ras-activated, human pancreatic carcinoma cell lines, radicicol inhibited K-Ras-induced hyperphosphorylation of Erk2. In addition, the level of Raf kinase was significantly decreased in radicicol-treated cells, whereas the levels of K-Ras and MAPK remained unchanged. These results suggest that radicicol disrupts the K-Ras-activated signaling pathway by selectively depleting Raf kinase and raises the possibility that pharmacological destabilization of Raf kinase could be a new and powerful approach for the treatment of K-ras-activated human cancers.


Archive | 1998

Peptides having cyclic structures and exerting p53 protein activty-restoring effect on p53 protein mutants

Kenji Shibata; Motoo Yamasaki; Tetsuo Yoshida; Tamio Mizukami; Akeo Shinkai; Hideharu Anazawa


Archive | 1997

E2f activity inhibitory compounds

Kenji Shibata; Motoo Yamasaki; Tetsuo Yoshida; Tamio Mizukami


Archive | 1994

Substance DC114-A1

Hirofumi Nakano; Noboru Fujii; Tamio Mizukami; Youichi Uosaki; Katsunori Kita; Eiji Kobayashi


Peptide science : proceedings of the ... Japanese Peptide Symposium | 1998

Synthesis and Activity of Cyclic Peptides Derives from the C-terminal Domain of p53 Restoring the Function of Mutant p53

Kenji Shibata; Tetsuo Yoshida; Shigeki Hatanaka; Tamio Mizukami; Motoo Yamasaki


Archive | 1998

Peptides having a cyclic structure and restoring the activities of p53 protein to mutant p53 protein

Kenji Shibata; Motoo Yamasaki; Tetsuo Yoshida; Tamio Mizukami; Akeo Shinkai; Hideharu Anazawa


Archive | 1997

Composes inhibant l'activite d'e2f

Kenji Shibata; Motoo Yamasaki; Tetsuo Yoshida; Tamio Mizukami


Archive | 1997

E2F activity-inhibiting compound

Kenji Shibata; Motoo Yamasaki; Tetsuo Yoshida; Tamio Mizukami


Archive | 1996

Herboxidiene derivatives and their preparation from streptomyces GEX1 culture

Shiro Akinaga; Tamio Mizukami; Keiko Ochiai; Yasushi Sakai; Youichi Uosaki; Tetsuo Yoshida


Archive | 1996

UCK14-Verbindungen UCK14 connections

Tamio Mizukami; Akira Asai; Yoshinori Yamashita; Ritsuko Katahira; Atsuhiro Hasegawa; Keiko Ochiai; Shiro Akinaga

Collaboration


Dive into the Tamio Mizukami's collaboration.

Top Co-Authors

Avatar

Kenji Shibata

University of Texas Southwestern Medical Center

View shared research outputs
Top Co-Authors

Avatar

Shiro Akinaga

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Tetsuo Yoshida

University of Texas Southwestern Medical Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Keiko Ochiai

Nagaoka University of Technology

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Akira Asai

Kumamoto Health Science University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge